Literature DB >> 8863585

Modified Ingelman-Sundberg bladder denervation procedure for intractable urge incontinence.

R D Cespedes1, C A Cross, E J McGuire.   

Abstract

PURPOSE: We determined the efficacy of the modified Ingelman-Sundberg procedure in women with urge incontinence and intractable detrusor instability.
MATERIALS AND METHODS: Women with urge incontinence and detrusor instability, in whom medical and behavioral therapy failed, received transvaginal local anesthesia to block the terminal pelvic nerve branches to the bladder. Urge incontinence resolved temporarily in 25 patients, who subsequently underwent modified Ingelman-Sundberg transvaginal bladder denervation. All patients underwent preoperative urodynamic evaluation but documented detrusor instability was not a requirement for surgery.
RESULTS: Of the patients 16 (64%) were cured of urge incontinence with substantial relief of detrusor instability, 2 (8%) had temporary improvement and 7 (28%) had no change. No patient who was cured required further surgery (mean followup 14.8 months, range 4 to 30). Use of anticholinergic agents also decreased dramatically: 5 patients used no, 9 used 1 and 2 used 2 medications. Detrusor instability was documented in 44% of the patients and was not predictive of operative outcome. There were no major complications of the procedure. Operative time was approximately 15 minutes.
CONCLUSIONS: In patients with urge incontinence and medically refractory detrusor instability, with few simple choices for treatment, the modified Ingelman-Sundberg procedure is an excellent surgical option that yields good results with minimal morbidity.

Entities:  

Mesh:

Year:  1996        PMID: 8863585

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  The overactive bladder.

Authors:  Richard Foon; Marcus J Drake
Journal:  Ther Adv Urol       Date:  2010-08

2.  Interventions for detrusor overactivity: the case for multimodal therapy.

Authors:  Roger Dmochowski
Journal:  Rev Urol       Date:  2002

3.  Initial clinical experience with selective bladder denervation for refractory overactive bladder.

Authors:  Le Mai Tu; Stefan De Wachter; Magali Robert; Roger R Dmochowski; Larry E Miller; Karel Everaert
Journal:  Neurourol Urodyn       Date:  2018-11-29       Impact factor: 2.696

4.  Refractory overactive bladder: Beyond oral anticholinergic therapy.

Authors:  Ronald W Glinski; Steven Siegel
Journal:  Indian J Urol       Date:  2007-04

Review 5.  Surgical management of overactive bladder.

Authors:  Michael Gross; Timothy B Boone; Rodney A Appell
Journal:  Curr Urol Rep       Date:  2002-10       Impact factor: 2.862

6.  OnabotulinumtoxinA Urethral Sphincter Injection as Treatment for Non-neurogenic Voiding Dysfunction - A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Yuan-Hong Jiang; Chung-Cheng Wang; Hann-Chorng Kuo
Journal:  Sci Rep       Date:  2016-12-13       Impact factor: 4.379

7.  Selective bladder denervation for overactive bladder (OAB) syndrome: From concept to healing outcomes using the ovine model.

Authors:  James Fugett; Lynette Phillips; Emily Tobin; Eric Whitbrook; Haydon Bennett; Joshua Shrout; James E Coad
Journal:  Neurourol Urodyn       Date:  2018-03-31       Impact factor: 2.696

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.